These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6444241)

  • 1. Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma.
    Siris ES; Sherman WH; Baquiran DC; Schlatterer JP; Osserman EF; Canfield RE
    N Engl J Med; 1980 Feb; 302(6):310-5. PubMed ID: 6444241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE; Siris ES; Jacobs TP
    Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
    Siris ES; Hyman GA; Canfield RE
    Am J Med; 1983 Mar; 74(3):401-6. PubMed ID: 6219577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.
    Attardo-Parrinello G; Merlini G; Pavesi F; Crema F; Fiorentini ML; Ascari E
    Arch Intern Med; 1987 Sep; 147(9):1629-33. PubMed ID: 2957971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
    Delmas P; Chapuy MC; Vignon E; Briançon D; Charhon S; Meunier PJ
    Nouv Presse Med; 1982 Apr; 11(19):1471-4. PubMed ID: 6210878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
    N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma.
    Delmas PD; Charhon S; Chapuy MC; Vignon E; Briancon D; Edouard C; Meunier PJ
    Metab Bone Dis Relat Res; 1982; 4(3):163-8. PubMed ID: 6218370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
    Paterson AD; Kanis JA; Cameron EC; Douglas DL; Beard DJ; Preston FE; Russell RG
    Br J Haematol; 1983 May; 54(1):121-32. PubMed ID: 6221750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dichloromethylene diphosphonate on bone metabolism in calcium and phosphorus-depleted rats.
    Evans RA; Wergedal JE; Baylink DJ
    Miner Electrolyte Metab; 1983; 9(3):119-24. PubMed ID: 6224075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
    Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP
    Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.
    Shane E; Baquiran DC; Bilezikian JP
    Ann Intern Med; 1981 Jul; 95(1):23-7. PubMed ID: 6264825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.
    Miller SC; Jee WS
    Anat Rec; 1979 Mar; 193(3):439-62. PubMed ID: 154858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
    Chapuy MC; Charhon SA; Meunier PJ
    Metab Bone Dis Relat Res; 1983; 4(6):325-8. PubMed ID: 6229683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New diphosphonates to block bone resorption.
    Raisz LG
    N Engl J Med; 1980 Feb; 302(6):347-8. PubMed ID: 6444242
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of dichloromethylene diphosphonate and vitamin D on bone of thyroparathyroidectomized rats.
    Weisbrode SE; Capen CC; Pendley CB
    Am J Pathol; 1977 Oct; 89(1):137-52. PubMed ID: 143891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.
    Berenson JR; Lichtenstein A; Porter L; Dimopoulos MA; Bordoni R; George S; Lipton A; Keller A; Ballester O; Kovacs MJ; Blacklock HA; Bell R; Simeone J; Reitsma DJ; Heffernan M; Seaman J; Knight RD
    N Engl J Med; 1996 Feb; 334(8):488-93. PubMed ID: 8559201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
    Douglas DL; Duckworth T; Kanis JA; Preston C; Beard DJ; Smith TW; Underwood I; Woodhead JS; Russell RG
    Arthritis Rheum; 1980 Oct; 23(10):1185-92. PubMed ID: 6448604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
    Jacobs TP; Siris ES; Bilezikian JP; Baquiran DC; Shane E; Canfield RE
    Ann Intern Med; 1981 Mar; 94(3):312-6. PubMed ID: 6452846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
    Elomaa I; Blomqvist C; Porkka L; Holmström T; Laine H
    Cancer Treat Rep; 1984 Apr; 68(4):655-7. PubMed ID: 6231989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.